Tetralogy of Fallot

Bailliard, Frederique; Anderson, Robert H.
January 2009
Orphanet Journal of Rare Diseases;2009, Vol. 4, p1
Academic Journal
Tetralogy of Fallot is a congenital cardiac malformation that consists of an interventricular communication, also known as a ventricular septal defect, obstruction of the right ventricular outflow tract, override of the ventricular septum by the aortic root, and right ventricular hypertrophy. This combination of lesions occurs in 3 of every 10,000 live births, and accounts for 7-10% of all congenital cardiac malformations. Patients nowadays usually present as neonates, with cyanosis of varying intensity based on the degree of obstruction to flow of blood to the lungs. The aetiology is multifactorial, but reported associations include untreated maternal diabetes, phenylketonuria, and intake of retinoic acid. Associated chromosomal anomalies can include trisomies 21, 18, and 13, but recent experience points to the much more frequent association of microdeletions of chromosome 22. The risk of recurrence in families is 3%. Useful diagnostic tests are the chest radiograph, electrocardiogram, and echocardiogram. The echocardiogram establishes the definitive diagnosis, and usually provides sufficient information for planning of treatment, which is surgical. Approximately half of patients are now diagnosed antenatally. Differential diagnosis includes primary pulmonary causes of cyanosis, along with other cyanotic heart lesions, such as critical pulmonary stenosis and transposed arterial trunks. Neonates who present with ductal-dependent flow to the lungs will receive prostaglandins to maintain ductal patency until surgical intervention is performed. Initial intervention may be palliative, such as surgical creation of a systemic-to-pulmonary arterial shunt, but the trend in centres of excellence is increasingly towards neonatal complete repair. Centres that undertake neonatal palliation will perform the complete repair at the age of 4 to 6 months. Follow-up in patients born 30 years ago shows a rate of survival greater than 85%. Chronic issues that now face such adults include pulmonary regurgitation, recurrence of pulmonary stenosis, and ventricular arrhythmias. As the strategies for surgical and medical management have progressed, the morbidity and mortality of those born with tetralogy of Fallot in the current era is expected to be significantly improved.


Related Articles

  • Array CGH as a first-tier test for neonates with congenital heart disease. Bachman, Kristine K.; DeWard, Stephanie J.; Chrysostomou, Constantinos; Munoz, Ricardo; Madan-Khetarpal, Suneeta // Cardiology in the Young;Jan2015, Vol. 25 Issue 1, p115 

    Objective: Efficient diagnosis of an underlying genetic aetiology in a patient with congenital heart disease is essential to optimising clinical care. Copy number variants are one aetiology of congenital heart disease; the majority are identifiable by targeted fluorescence in situ...

  • Emily’s Story. Sittig, Steven E. // AARC Times;Sep2014, Vol. 38 Issue 9, p26 

    The article offers a clinical perspective on challenges in detecting neonatal congenital heart disease (CHD). It discusses the advantages of using pulse oximetry screening for detecting CHD during routine newborn physical examination and for identifying seven ductal-dependent lesions. A diagram...

  • 胎儿先天性心脏病与染色体及22q11微缺失异常的临床研究. 闫亚妮; 吴青青; 姚 苓; 王 欣; 山 丹; 安园园; 高凤云 // Journal of Xi'an Jiaotong University (Medical Sciences);Mar2014, Vol. 35 Issue 2, p249 

    Objective To investigate the association between congenital heart disease (CHD) and chromosome abnormalities by routine prenatal ultrasound and echocardiography screening to explore the etiology of fetal CHD. Methods Patients with fetal CHD who underwent chromosome examinations from January...

  • The Fourth Vital Sign. Stafford, Rick // Fairfield County Business Journal;4/28/2014 Supplement, p3 

    The article discusses pulse oximetry screening which can detect cyanotic congenital heart defect in newborns for early detection, intervention, and treatment, highlighting the views of physician Rick Stafford on the issue.

  • Regional Implementation of Newborn Screening for Critical Congenital Heart Disease Screening in Abu Dhabi. Al Mazrouei, Shereena; Moore, Jennifer; Ahmed, Faiza; Mikula, Elizabeth; Martin, Gerard // Pediatric Cardiology;Aug2013, Vol. 34 Issue 6, p1299 

    Congenital heart disease (CHD) is the most common birth defect and affects approximately 8 out of every 1,000 infants born each year. Despite antenatal screening and at least one examination before discharge infants with critical CHD (CCHD) are routinely not detected before discharge from the...

  • Dexmedetomidine utilisation and outcomes of children with trisomy 21 undergoing congenital heart disease surgery. Moffett, Brady S.; Mossad, Emad B.; Tobias, Joseph D.; Cabrera, Antonio G. // Cardiology in the Young;Jun2015, Vol. 25 Issue 5, p958 

    Introduction: The diagnosis of trisomy 21 in children has been associated with failed extubation after CHD surgery. Dexmedetomidine may be a useful agent to improve postoperative outcomes in these patients, such as ventilator time, ICU length of stay, or hospital length of stay. Materials and...

  • Congenital Heart Disease: Causes, Diagnosis, Symptoms, and Treatments. Sun, RongRong; Liu, Min; Lu, Lei; Zheng, Yi; Zhang, Peiying // Cell Biochemistry & Biophysics;Jul2015, Vol. 72 Issue 3, p857 

    The congenital heart disease includes abnormalities in heart structure that occur before birth. Such defects occur in the fetus while it is developing in the uterus during pregnancy. About 500,000 adults have congenital heart disease in USA (WebMD, Congenital heart defects medications, , ). 1 in...

  • Newborn congenital heart defect screening burden low, requires consistency.  // Cardiology Today;Jun2013, Vol. 16 Issue 6, p23 

    The article discusses research being done on a statewide screening protocol for critical congenital heart defects in newborns initiated in New Jersey.

  • Extracardiac malformations: associations and importance: consequences for perinatal management of foetal cardiac patients. Oepkes, Dick; Haak, Monique // Cardiology in the Young;Oct2014 Supplement, Vol. 24, p55 

    Foetal echocardiography has become an established subspecialty in paediatric cardiology. The skills to perform detailed assessment of foetal cardiac anomalies in a tiny, moving foetus surrounded by sometimes challenging layers of maternal tissue are not easy to obtain, and require prolonged...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics